Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186,164,820
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
108,080,099
-
Shares change
-
+20,016,614
-
Total reported value, excl. options
-
$2,339,923,951
-
Value change
-
+$420,541,164
-
Put/Call ratio
-
66%
-
Number of buys
-
106
-
Number of sells
-
-44
-
Price
-
$21.66
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q1 2023
168 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q1 2023.
Revolution Medicines, Inc. - Common Stock (RVMD) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 108,080,099 shares
of 186,164,820 outstanding shares and own 58% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (10,425,368 shares), VANGUARD GROUP INC (9,302,553 shares), BlackRock Inc. (7,465,774 shares), EcoR1 Capital, LLC (5,352,183 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,035,179 shares), BVF INC/IL (4,955,588 shares), Nextech Invest Ltd. (4,839,529 shares), STATE STREET CORP (4,811,431 shares), Bellevue Group AG (4,747,900 shares), and Boxer Capital, LLC (4,684,264 shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.